Amphix Bio | $12,500,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
Katalist | $1,500,000 | (Dec 19, 2025)
Certified by Founder
Lodge
VerImmune
start up
United States
- Washington DC
- 21/09/2023
- Unknown
- $3,000,000
VerImmune is advancing Anti-tumor Immune Redirection (AIR):
A Breakthrough Therapy that Redirects Pre-Existing Immune Memory
from Childhood Vaccination or Infection to Fight Cancer
- Industry Biotechnology
- Website https://www.verimmune.com/
- LinkedIn https://www.linkedin.com/company/verimmune/about/
Related People
Joshua Weiyuan WangFounder
United States -
Washington, District of Columbia
Joshua Wang is a bio-entrepreneur with experience in founding, securing early stage financing and operating early stage biotech companies. His technical background in virology, vaccines and immunology inform his mindful but competitive approach to evolve scientific discoveries into medicines to serve critical unmet needs. Joshua’s experience spans the globe having lived and worked in Singapore, the UK and USA currently.
Syremis Therapeutics | $165,000,000 | (Dec 19, 2025)
Gravity Labs Co., Ltd. | $17,000,000 | (Dec 19, 2025)
Edison Scientific | $70,000,000 | (Dec 19, 2025)
InfiniteWatch | $4,000,000 | (Dec 19, 2025)
Thread | $18,000,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
SkillCorner | $60,000,000 | (Dec 19, 2025)
Wearlinq | $14,000,000 | (Dec 18, 2025)
T-CURX GmbH | $20,000,000 | (Dec 18, 2025)